Targeting the tumor necrosis factor-related apoptosis-inducing ligand path in neuroblastoma

Cancer Letters

Volumn 197, Issue 1-2, 2003, Pages 137-143

  Yang, Xuezhong ^a   Thiele, Carol J ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Amplification; Caspase 8; Cytotoxic; Death receptor; Demethylation; FAS; Interferon ; Methylation; Multiple lesions; MYCN; N myc; Neuroblastoma; Promoter; Stoichiometrical model; TR1; TR2; TrkA; TrkB; Tumor necrosis factor related apoptosis inducing ligand

Indexed keywords

CASPASE 8; GAMMA INTERFERON; TUMOR NECROSIS FACTOR RECEPTOR; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND;

APOPTOSIS; CANCER CELL CULTURE; CANCER GROWTH; CONFERENCE PAPER; CORRELATION ANALYSIS; DEMETHYLATION; ENZYME DEFICIENCY; ENZYME INDUCTION; GENE ACTIVATION; GENE TARGETING; GENETIC TRANSDUCTION; HETEROLOGOUS EXPRESSION; HUMAN; MOLECULAR DYNAMICS; NEUROBLASTOMA; NEUROBLASTOMA CELL; ONCOGENE C MYB; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN METHYLATION; STOICHIOMETRY;

EID: 0038444699     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3835(03)00093-4     Document Type: Conference Paper

References (22)

1. Wiley S.R., Schooley K., Smolak P.J., Din W.S., Huang C.P., Nicholl J.K., Sutherland G.R., Smith T.D., Rauch C., Smith C.A. Identification and characterization of a new member of the TNF family that induces apoptosis. Immunity. 3:1995;673-682.
2. Ashkenazi A., Pai R.C., Fong S., Leung S., Lawrence D.A., Marsters S.A., Blackie C., Chang L., McMurtrey A.E., Hebert A., DeForge L., Koumenis I.L., Lewis D., Harris L., Bussiere J., Koeppen H., Shahrokh Z., Schwall R.H. Safety and antitumor activity of recombinant soluble Apo2 ligand. J. Clin. Invest. 104:1999;155-162.
3. Ichikawa K., Liu W., Zhao L., Wang Z., Liu D., Ohtsuka T., Zhang H., Mountz J.D., Koopman W.J., Kimberly R.P., Zhou T. Tumoricidal activity of a novel anti-human DR5 monoclonal antibody without hepatocyte cytotoxicity. Nat. Med. 7:2001;954-960.
4. Chaudhary P.M., Eby M., Jasmin A., Bookwalter A., Murray J., Hood L. Death receptor 5, a new member of the TNFR family, and DR4 induce FADD-dependent apoptosis and activate the NF-kappaB pathway. Immunity. 7:1997;821-830.
5. Sprick M.R., Weigand M.A., Rieser E., Rauch C.T., Juo P., Blenis J., Krammer P.H., Walczak H. FADD/MORT1 and caspase-8 are recruited to TRAIL receptors 1 and 2 and are essential for apoptosis mediated by TRAIL receptor 2. Immunity. 12:2000;599-609.
6. Kischkel F.C., Lawrence D.A., Chuntharapai A., Schow P., Kim K.J., Ashkenazi A. Apo2L/TRAIL-dependent recruitment of endogenous FADD and caspase-8 to death receptors 4 and 5. Immunity. 12:2000;611-620.
7. Miyazaki T., Reed J.C. A GTP-binding adapter protein couples TRAIL receptors to apoptosis-inducing proteins. Nat. Immunol. 2:2001;493-500.
8. Fernandes-Alnemri T., Armstrong R.C., Krebs J., Srinivasula S.M., Wang L., Bullrich F., Fritz L.C., Trapani J.A., Tomaselli K.J., Litwack G., Alnemri E.S. In vitro activation of CPP32 and Mch3 by Mch4, a novel human apoptotic cysteine protease containing two FADD-like domains. Proc. Natl. Acad. Sci. USA. 93:1996;7464-7469.
9. Teitz T., Wei T., Valentine M.B., Vanin E.F., Grenet J., Valentine V.A., Behm F.G., Look A.T., Lahti J.M., Kidd V.J. Caspase 8 is deleted or silenced preferentially in childhood neuroblastomas with amplification of MYCN. Nat. Med. 6:2000;529-535.
10. Hopkins-Donaldson S., Bodmer J.L., Bourloud K.B., Brognara C.B., Tschopp J., Gross N. Loss of caspase-8 expression in highly malignant human neuroblastoma cells correlates with resistance to tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis. Cancer Res. 60:2000;4315-4319.
11. Eggert A., Grotzer M.A., Zuzak T.J., Wiewrodt B.R., Ho R., Ikegaki N., Brodeur G.M. Resistance to tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced apoptosis in neuroblastoma cells correlates with a loss of caspase-8 expression. Cancer Res. 61:2001;1314-1319.
12. Santini V., Kantarjian H.M., Issa J.P. Changes in DNA methylation in neoplasia: pathophysiology and therapeutic implications. Ann. Intern. Med. 134:2001;573-586.
13. Dai C., Krantz S.B. Interferon gamma induces upregulation and activation of caspases 1, 3, and 8 to produce apoptosis in human erythroid progenitor cells. Blood. 93:1999;3309-3316.
14. Fulda S., Debatin K.M. IFNgamma sensitizes for apoptosis by upregulating caspase-8 expression through the Stat1 pathway. Oncogene. 21:2002;2295-2308.
15. X. Yang, M.S. Merchant, M.E. Romero, M. Tsokos, L.H. Wexler, U. Kontny, C.L. Mackall, C.J. Thiele, Induction of caspase 8 by IFN-g renders some NB cells TRAIL sensitive but reveals that a lack of membrane TR1/TR2 also contributes to TRAIL resistance in NB, Cancer Res., 2003, in press.
16. Takimoto R., El-Deiry W.S. Wild-type p53 transactivates the KILLER/DR5 gene through an intronic sequence-specific DNA-binding site. Oncogene. 19:2000;1735-1743.
17. Deng Y., Lin Y., Wu X. TRAIL-induced apoptosis requires Bax-dependent mitochondrial release of Smac/DIABLO. Genes Dev. 16:2002;33-45.
18. Fulda S., Wick W., Weller M., Debatin K.M. Smac agonists sensitize for Apo2L/TRAIL- or anticancer drug-induced apoptosis and induce regression of malignant glioma in vivo. Nat. Med. 8:2002;808-815.
19. Hoffman B., Liebermann D.A. The proto-oncogene c-myc and apoptosis. Oncogene. 17:1998;3351-3357.
20. Fulda S., Lutz W., Schwab M., Debatin K.M. MycN sensitizes neuroblastoma cells for drug-induced apoptosis. Oncogene. 18:1999;1479-1486.
21. Scala S., Wosikowski K., Giannakakou P., Valle P., Biedler J.L., Spengler B.A., Lucarelli E., Bates S.E., Thiele C.J. Brain-derived neurotrophic factor protects neuroblastoma cells from vinblastine toxicity. Cancer Res. 56:1996;3737-3742.
22. Jaboin J., Kim C.J., Kaplan D.R., Thiele C.J. Brain-derived neurotrophic factor activation of TrkB protects neuroblastoma cells from chemotherapy-induced apoptosis via phosphatidylinositol 3′-kinase pathway. Cancer Res. 62:2002;6756-6763.